Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**RNA, 7SL, cytoplasmic 545, pseudogene (RN7SL545P)** is a human pseudogene derived from the 7SL RNA gene, which is an essential component of the signal recognition particle (SRP) involved in the targeting and translocation of proteins to the endoplasmic reticulum. However, RN7SL545P is a non-functional, non-coding segment of genomic DNA that does not produce functional RNA or protein. Human DNA contains hundreds of 7SL RNA-like sequences, most of which are pseudogenes, and these are typically inactive due to truncations or sequence mutations resulting from retrotransposition. There is currently no evidence that RN7SL545P functions as a therapeutic target, biomarker, or has clinically validated disease associations. Its biological role is thus limited to that of a processed pseudogene, although pseudogenes in general may occasionally act as competitive endogenous RNAs or have post-transcriptional regulatory effects, but such functions have not been described specifically for RN7SL545P[1][4][7][8][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 545, pseudogene (RN7SL545P).